Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Neurology

• Publication date

  1999-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s004150050345
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of resistance to botulinum toxin type A in patients with torticollis

  2004cited by this paper
• The EDB Test—A clinical test for the detection of antibodies to botulinum toxin type A

  1997cited by this paper
• Frequency of familial inheritance among 488 index patients with idiopathic focal dystonia and clinical variability in a large family

  1997cited by this paper
• Botulinum toxin therapy, immunologic resistance, and problems with available materials

  1996cited by this paper
• Response and immunoresistance to botulinum toxin injections

  1995cited by this paper
• Immunogenicity of the neurotoxins of Clostridium botulinum

  1994cited by this paper
• Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia

  1993cited by this paper
• Botulinum antibodies in dystonic patients treated with type A botulinum toxin

  1993cited by this paper
• Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system.

  1992cited by this paper
• Dystonia--a clinical, neuropathological and therapeutic review.

  1992cited by this paper
• Antitoxins and botulinum toxin treatment.

  1992cited by this paper
• A double blind trial of botulinum toxin "A" in torticollis, with one year follow up.

  1991cited by this paper
• Change in pattern of muscle activity following botulinum toxin injections for torticollis

  1991cited by this paper
• Distant effects of locally injected botulinum toxin: A double‐blind study of single fiber EMG changes

  1991cited by this paper
• Treatment of idiopathic spasmodic torticollis with botulinum toxin a: A double‐blind study on twenty‐three patients

  1991cited by this paper
• [Treatment of spasmodic torticollis with local injections of botulinum toxin A].

  1991cited by this paper
• Botulinum toxin injections for cervical dystonia

  1990cited by this paper
• Botulinum toxin treatment in spasmodic torticollis.

  1990cited by this paper
• Double‐blind, placebo‐controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis

  1990cited by this paper
• Lokale Injektionen von Botulinum-Toxin A bei zervikaler Dystonie: Verlaufsbeobachtungen an 45 Patienten

  1990cited by this paper
• Natural history of adult-onset idiopathic torticollis.

  1990cited by this paper
• Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis

  1989cited by this paper
• Botulinum toxin in spasmodic torticollis.

  1988cited by this paper
• Epidemiology of focal and generalized dystonia in Rochester, Minnesota

  1988cited by this paper
• Botulinum A toxin for cranial‐cervical dystonia

  1987cited by this paper
• Double-blind study of botulinum toxin in spasmodic torticollis.

  1986cited by this paper
• A Pilot Study on the Use of Botulinum Toxin in Spasmodic Torticollis

  1985cited by this paper

• DaxibotulinumtoxinA for Injection in Adults with Cervical Dystonia: Clinical Insights from a Real-World Early Experience Program.

  2026cites this paper
• A Pilot Study of Differences in Antibody Responses of Intradermal and Intramuscular Injections of Botulinum Toxin Type A

  2025cites this paper
• Botulinum Therapy for Pain Caused by Spasticity in Advanced Stages of Brain Tumor in Adolescents: A Case Report

  2025cites this paper
• The Effective Way of Botulinum Toxin Injection to Reduce Bite Force: Preliminary Study

  2025cites this paper
• Immunogenicity of Botulinum Toxin A: Insights

  2024cites this paper
• Patient Characteristics and Real-World Use of Botulinum Toxins for the Treatment of Cervical Dystonia, Blepharospasm, and Hemifacial Spasm

  2024cites this paper
• Design and development of an intelligent neck and head support system based on eye blink recognition for cervical dystonia

  2024cites this paper
• Doses of Botulinum Toxin in Cervical Dystonia: Does Ultrasound Guidance Change Injection Practices?

  2024cites this paper
• Genetic Update and Treatment for Dystonia

  2024cites this paper
• Comparison of Oropharyngeal Dysphagia Before and After Botulinum Toxin Injection in Cervical Dystonia

  2023cites this paper
• Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review

  2023cites this paper
• Deep Brain Stimulation for Focal or Segmental Craniocervical Dystonia in Patients Who Have Failed Botulinum Neurotoxin Therapy—A Narrative Review of the Literature

  2023cites this paper
• “Pseudo”-Secondary Treatment Failure Explained via Disease Progression and Effective Botulinum Toxin Therapy: A Pilot Simulation Study

  2023cites this paper
• Exploring the Interplay between the Clinical and Presumed Effect of Botulinum Injections for Cervical Dystonia: A Pilot Study

  2023cites this paper
• Classification of Dystonia

  2022cites this paper
• The complex relationship between antibody titers and clinical outcome in botulinum toxin type A long-term treated patients with cervical dystonia

  2022cites this paper
• The Use of High Initial Doses of Botulinum Toxin Therapy for Cervical Dystonia Is a Risk Factor for Neutralizing Antibody Formation—A Monocentric Cross-Sectional Pilot Study

  2022cites this paper
• The Immunology of Botulinum Toxin Therapy: A Brief Summary.

  2022cites this paper
• Long-term efficacy with deep brain stimulation of the globus pallidus internus in cervical dystonia: a retrospective monocentric study

  2022cites this paper
• Botulinum Toksinin Gummy Smile Tedavisinde Kullanımı

  2022cites this paper
• Botulinum Toxin in the Treatment of Cervical Dystonia: Evidence-Based Review

  2022cites this paper
• Significant Long-Lasting Improvement after Switch to Incobotulinum Toxin in Cervical Dystonia Patients with Secondary Treatment Failure

  2022cites this paper
• Botulinum toxin in the management of myalgia in temporomandibular disorders: are all injections equal?

  2022cites this paper
• Contribution of Single-Fiber Evaluation on Monitoring Outcomes Following Injection of Botulinum Toxin-A: A Narrative Review of the Literature

  2021cites this paper
• Botulinum Toxin Type A for Aesthetic Use: Middle and Lower Third of the Face and Neck

  2021cites this paper
• The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia

  2021cites this paper
• Botulinum Toxin in Movement Disorders: An Update

  2021cites this paper
• Clinical Improvement After Treatment With IncobotulinumtoxinA (XEOMIN®) in Patients With Cervical Dystonia Resistant to Botulinum Toxin Preparations Containing Complexing Proteins

  2021cites this paper
• Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisal

  2021cites this paper
• Management of Secondary Poor Response to Botulinum Toxin in Cervical Dystonia: A Multicenter Audit

  2021cites this paper
• Clinical Implications of Difference in Antigenicity of Different Botulinum Neurotoxin Type A Preparations: Clinical Take-Home Messages from Our Research Pool and Literature

  2020cites this paper
• Use of AbobotulinumtoxinA in Adults with Cervical Dystonia: A Systematic Literature Review

  2020cites this paper
• Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy

  2020cites this paper
• Which factors impact on quality of life for adults with blepharospasm and hemifacial spasm?

  2020cites this paper
• The impact of the initial severity on later outcome: retrospective analysis of a large cohort of botulinum toxin naïve patients with idiopathic cervical dystonia

  2020cites this paper
• Benefits, Safety, and Adjunct Modality Prevalences of Long-Term Botulinum Toxin Injections for Cervical Dystonia and Myofascial Neck Pain: A Retrospective Cohort Study

  2020cites this paper
• Antibody‐induced botulinum toxin treatment failure: A review and novel management approach

  2020cites this paper
• Frequency and risk factors of antibody-induced secondary failure of botulinum neurotoxin therapy

  2020cites this paper
• An Improved Technique on Existing Neck and Head Support Systems for Cervical Dystonia

  2020cites this paper
• Effective botulinum toxin injection guide for treatment of cervical dystonia

  2020cites this paper
• Atlas of Surgical Therapy for Migraine and Tension-Type Headache

  2020cites this paper
• Immunogenicity induced by botulinum toxin injections for limb spasticity: A systematic review.

  2019cites this paper
• Treatment of cervical dystonia with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice

  2019cites this paper
• Immunogenicity Associated with Botulinum Toxin Treatment

  2019cites this paper
• Pallidal neurostimulation versus botulinum toxin injections in the treatment of cervical dystonia: protocol of a randomized, sham-controlled trial (StimTox-CD)

  2019cites this paper
• Safety and Efficacy of Intracavernosal Injections of AbobotulinumtoxinA (Dysport®) as Add on Therapy to Phosphosdiesterase Type 5 Inhibitors or Prostaglandin E1 for Erectile Dysfunction—Case Studies

  2019cites this paper
• Botulinum Neurotoxin: Basic Facts, Physiology and Pharmacology

  2019cites this paper
• Clinical relevance of neutralizing antibodies in botulinum toxin long-term treated still-responding patients with cervical dystonia

  2019cites this paper
• Cervical dystonia: an update on therapeutics

  2019cites this paper
• Deep Brain Stimulation Versus Peripheral Denervation for Cervical Dystonia: A Systematic Review and Meta-Analysis.

  2019cites this paper
• Contemporary Review and Case Report of Botulinum Resistance in Facial Synkinesis

  2018cites this paper
• The Treatment of Axial and Foot Dystonia

  2018cites this paper
• Towards flexible and tailored botulinum neurotoxin dosing regimens for focal dystonia and spasticity - Insights from recent studies.

  2018cites this paper
• Can botulinum toxin cause chronic muscle weakness?

  2018cites this paper
• Quality of life in long-term botulinum toxin treatment of cervical dystonia: Results of a cross sectional study.

  2018cites this paper
• Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?

  2017cites this paper
• Botulinum toxin for treatment of the focal dystonia.

  2017cites this paper
• Injectable and topical neurotoxins in dermatology: Indications, adverse events, and controversies.

  2017cites this paper
• Immunological aspects of botulinum toxin therapy

  2017cites this paper
• Botulinum Toxin for the Treatment of Neuropathic Pain

  2017cites this paper
• Successful use of botulinum toxin a in intractable, severe muscle spasms in spinal cord injury: A case report

  2017cites this paper
• Systematic analysis of botulinum neurotoxin type A immunogenicity in clinical studies

  2017cites this paper
• Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin

  2017cites this paper
• Abobotulinumtoxin: Development and Aesthetic Usage

  2017cites this paper
• Use of a botulinum toxin A in dentistry and oral and maxillofacial surgery

  2016cites this paper
• British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin

  2016cites this paper
• Botulinum Toxin Treatment of Cervical Dystonia

  2016cites this paper
• Unmet Needs in the Management of Cervical Dystonia

  2016cites this paper
• Anatomical Regional Targeted (ART) BOTOX Injection Technique: A Novel Paradigm for Migraines and Chronic Headaches

  2016cites this paper
• High Botulinum Toxin‐Neutralizing Antibody Prevalence Under Long‐Term Cervical Dystonia Treatment

  2016cites this paper
• The Most Cited Works in Essential Tremor and Dystonia

  2016cites this paper
• WITHDRAWN: Botulinum toxin for subacute/chronic neck pain.

  2015cites this paper
• Neutralizing Antibody and Botulinum Toxin Therapy: A Systematic Review and Meta-analysis

  2015cites this paper
• Lumbar Sympathetic Block with Botulinum Toxin Type B for Complex Regional Pain Syndrome: A Case Study.

  2015cites this paper
• Is it time for flexibility in botulinum inter-injection intervals?

  2015cites this paper
• Botulinum toxin for the treatment of bruxism

  2015cites this paper
• Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A

  2015cites this paper
• Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia.

  2015cites this paper
• Serious and Long-Term Adverse Events Associated with the Therapeutic and Cosmetic Use of Botulinum Toxin

  2015cites this paper
• Long-Term Treatment of Focal Dystonias (Cervical and Writer’s Cramp): Clinical and Quality of Life Impact

  2015cites this paper
• Clinical differences between botulinum neurotoxin type A and B.

  2015influential citation
• Electrophysiological Recording of the Brain, Visualization, Prediction, and Interconnectivity

  2014cites this paper
• Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial.

  2014cites this paper
• Clinical Use of Botulinum Neurotoxin: Neuromuscular Disorders

  2014cites this paper
• Therapeutic applications of botulinum neurotoxins in head and neck disorders

  2014cites this paper
• Microvascular decompression surgery is effective for the laterocollis subtype of spasmodic torticollis: a long-term follow-up result

  2014cites this paper
• Botulinum Toxin Therapy for Cervical Dystonia: The Science of Dosing

  2014cites this paper
• Clinical Applications of Botulinum Neurotoxin

  2014cites this paper
• Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up.

  2014cites this paper
• Clinical Use of Botulinum Neurotoxins: Pain

  2014cites this paper
• Botulinum Toxin as a Clinical Product: Manufacture and Pharmacology

  2014cites this paper
• Very early reduction in efficacy of botulinum toxin therapy for cervical dystonia in patients with subsequent secondary treatment failure: a retrospective analysis

  2013influential citation
• Comparative Evaluation of Surgical Procedures for Trigeminal Neuralgia

  2013cites this paper
• Is age associated with the development of antibodies against botulinum toxin?

  2013cites this paper
• Abo‐, Inco‐, Ona‐, and Rima‐Botulinum Toxins in Clinical Therapy: A Primer

  2013cites this paper
• Long-Term Efficacy, Safety, and Side Effect Profile of Botulinum Toxin Injections in Dystonia – A 20-Year Follow-Up (P07.197)

  2013cites this paper
• Uso de toxina botulínica en neurología: Experiencia en el Hospital Guillermo Almenara Irigoyen, EsSalud

  2013cites this paper
• The Cost‐Effectiveness of Periodic Safety Update Reports for Biologicals in Europe

  2013cites this paper
• Conocimientos básicos sobre la toxina botulínica para una utilización terapéutica

  2013cites this paper
• Long-Term Efficacy and Safety of Botulinum Toxin Injections in Dystonia

  2013influential citation